Ono Pharmaceutical Valuation
| OPHLY Stock | USD 3.59 0.09 2.45% |
At this time, the company appears to be undervalued. Ono Pharmaceutical holds a recent Real Value of $3.84 per share. The prevailing price of the company is $3.59. Our model determines the value of Ono Pharmaceutical from analyzing the company fundamentals such as Shares Outstanding of 1.47 B, return on equity of 0.16, and Operating Margin of 0.35 % as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Ono Pharmaceutical's price fluctuation is somewhat reliable at this time. Calculation of the real value of Ono Pharmaceutical is based on 3 months time horizon. Increasing Ono Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ono Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ono Pink Sheet. However, Ono Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.59 | Real 3.84 | Hype 3.59 |
The intrinsic value of Ono Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ono Pharmaceutical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ono Pharmaceutical Co helps investors to forecast how Ono pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ono Pharmaceutical more accurately as focusing exclusively on Ono Pharmaceutical's fundamentals will not take into account other important factors: Ono Pharmaceutical Total Value Analysis
Ono Pharmaceutical Co is now expected to have takeover price of 11.13 B with market capitalization of 10.55 B, debt of 8.65 B, and cash on hands of 136.18 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Ono Pharmaceutical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.13 B | 10.55 B | 8.65 B | 136.18 B |
Ono Pharmaceutical Investor Information
The book value of the company was now reported as 491.93. The company last dividend was issued on the 29th of September 2022. Ono Pharmaceutical had 3:1 split on the 4th of April 2016. Ono Pharmaceutical Co is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Ono Pharmaceutical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ono Pharmaceutical has an asset utilization ratio of 48.89 percent. This suggests that the Company is making $0.49 for each dollar of assets. An increasing asset utilization means that Ono Pharmaceutical Co is more efficient with each dollar of assets it utilizes for everyday operations.Ono Pharmaceutical Ownership Allocation
Ono Pharmaceutical owns a total of 1.47 Billion outstanding shares. Roughly 99.97 pct. of Ono Pharmaceutical outstanding shares are held by general public with 0.03 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Ono Pharmaceutical Profitability Analysis
The company reported the revenue of 361.36 B. Net Income was 80.52 B with profit before overhead, payroll, taxes, and interest of 267.85 B.About Ono Pharmaceutical Valuation
Our relative valuation model uses a comparative analysis of Ono Pharmaceutical. We calculate exposure to Ono Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ono Pharmaceutical's related companies.Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. The company was founded in 1717 and is headquartered in Osaka, Japan. Ono Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 3687 people.
8 Steps to conduct Ono Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ono Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ono Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ono Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ono Pharmaceutical's revenue streams: Identify Ono Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ono Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ono Pharmaceutical's growth potential: Evaluate Ono Pharmaceutical's management, business model, and growth potential.
- Determine Ono Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ono Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Ono Pharmaceutical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.5 B | |
| Quarterly Earnings Growth Y O Y | 0.853 | |
| Forward Price Earnings | 11.8343 | |
| Retained Earnings | 644.8 B |
Additional Tools for Ono Pink Sheet Analysis
When running Ono Pharmaceutical's price analysis, check to measure Ono Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ono Pharmaceutical is operating at the current time. Most of Ono Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Ono Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ono Pharmaceutical's price. Additionally, you may evaluate how the addition of Ono Pharmaceutical to your portfolios can decrease your overall portfolio volatility.